Join
Live feed
·
PRReleasevia Quantisnow
Biotricity Inc. logo

Biotricity Reports Strong Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses for Fiscal Year 2024, Accelerating the Company's Path to Profitability

ByQuantisnow·Wall Street's wire, on your screen.
BTCY· Biotricity Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BTCY (Biotricity Inc.) and more on Quantisnow.